Michelle Ross, StemPoint Capital CIO, joins ‘Closing Bell’ to discuss the small and mid-cap biotech stocks, the patent cliff coming for the companies in the sector and much more.
StemPoint Capital | ‘Closing Bell’
•
1 min read
Related Posts
Watch Iva Green, CIO of Pearlstone Alternative, discuss the impact of higher rates, widening credit dispersion, and the growing opportunity set for fundamental credit selection in Europe.
Click to see a collection of charts pertaining to the digital assets landscape.
Michelle Ross, Stempoint Capital CIO, joins ‘Closing Bell’ to talk her perspective on the Biotech sector, companies she is watching in the space, and more.